Table 2 Baseline characteristics of patients stratified for CTO lesion Revascularized or Not
Variable | CTO-R group (n = 300) | CTO-NR group (n = 263) | P |
|---|---|---|---|
Age | 63 ± 10 | 67 ± 11 | < 0.001 |
Male | 248 (82.7) | 208 (79.1) | 0.28 |
Days | 7 (5,9) | 6 (5,8) | 0.721 |
BMI (kg/m2) | 26.19 ± 3.59 | 25.85 ± 3.2 | 0.242 |
AC (cm) | 93.36 ± 9.96 | 93.67 ± 9.77 | 0.721 |
Smoke | 200 (66.7) | 171 (65) | 0.681 |
Drink | 63 (21) | 50 (19) | 0.557 |
HT | 220 (73.3) | 193 (73.4) | 0.989 |
DM | 119 (39.7) | 140 (53.2) | 0.001 |
Hyperlipemia | 162 (54) | 157 (59.7) | 0.174 |
CHD | 177 (59) | 167 (63.5) | 0.275 |
OMI | 58 (19.3) | 68 (25.9) | 0.064 |
HF | 4 (1.3) | 4 (1.5) | 0.851 |
CKD | 11 (3.7) | 23 (8.7) | 0.012 |
PAD | 21 (7) | 21 (8) | 0.657 |
Stroke | 63 (21) | 58 (22.1) | 0.761 |
History of PCI | 88 (29.3) | 88 (33.5) | 0.292 |
History of CABG | 3 (1) | 20 (7.6) | < 0.001 |
CHOL (mmol/L) | 4.13 ± 1.09 | 3.9 ± 1.01 | 0.013 |
LDL-C (mmol/L) | 2.34 ± 0.76 | 2.2 ± 0.73 | 0.036 |
eGFR (ml/min) | 86.24 ± 20.57 | 80.15 ± 23.37 | 0.001 |
NT-proBNPmax (Pg/ml) | 278 (81,1034.75) | 487 (144,2223) | 0.001 |
LVEDD | 5.23 ± 0.64 | 5.27 ± 0.59 | 0.43 |
LVEF | 0.61 ± 0.1 | 0.58 ± 0.11 | 0.001 |
FS | 0.33 ± 0.07 | 0.31 ± 0.07 | 0.002 |
ISR | 25 (8.3) | 12 (4.6) | 0.072 |
three vessel disease | 270 (90) | 253 (96.2) | 0.004 |
LM disease | 41 (13.7) | 66 (25.1) | 0.001 |